11.07.2015 Views

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

372 IV. SPECIAL POPULATIONSTABLE 17.1. Aberrant Drug-Relat<strong>ed</strong> BehaviorsBehaviors more suggestive <strong>of</strong> an addiction disorder• Selling prescription drugs• Prescription forgery• Stealing or “borrowing” drugs from others• Injecting oral formulations• Obtaining prescription drugs from nonm<strong>ed</strong>ical sources• Obtaining drugs from multiple m<strong>ed</strong>ical sources without informing or despiteprohibition• Concurrent abuse <strong>of</strong> alcohol or illicit drugs• Multiple episodes <strong>of</strong> self-escalation <strong>of</strong> dose, despite warnings not to do so• Multiple episodes <strong>of</strong> prescription “loss”• Evidence <strong>of</strong> functional deterioration unexplain<strong>ed</strong> by the pain or other comorbidity• Repeat<strong>ed</strong> resistance to changes in therapy despite clear evidence <strong>of</strong> adverse effectsBehaviors less suggestive <strong>of</strong> an addiction disorder• Aggressive complaining about the ne<strong>ed</strong> for more drug• Drug hoarding during periods <strong>of</strong> r<strong>ed</strong>uc<strong>ed</strong> symptoms• Requesting specific drugs• Openly acquiring similar drugs from other m<strong>ed</strong>ical sources• Occasional unsanction<strong>ed</strong> dose escalation• Unapprov<strong>ed</strong> use <strong>of</strong> the drug to treat another symptom• Reporting psychic effects not intend<strong>ed</strong> by the clinician• Resistance to a change in therapy associat<strong>ed</strong> with “tolerable” adverse effects• Expression <strong>of</strong> family concerns(Weissman & Haddox, 1989), the term is now commonly appli<strong>ed</strong> to patientswith any type <strong>of</strong> chronic pain.Patients with addiction also may develop an increase in drug seeking thatis driven by uncontroll<strong>ed</strong> pain. In some cases, this behavior reflects both addictionand pseudoaddiction. If the patient is receiving a prescrib<strong>ed</strong> opioid forpain, the diagnosis may only be clarifi<strong>ed</strong> if m<strong>ed</strong>ical access to the drug isincreas<strong>ed</strong> in a structur<strong>ed</strong> plan. Should drug-seeking behavior continue in thiscontext, the likelihood that pseudoaddiction pr<strong>ed</strong>ominates is less.TABLE 17.2. Differential Diagnosis <strong>of</strong> Aberrant Drug-Relat<strong>ed</strong> Behavior• Addiction• Pseudoaddiction• Psychiatric disorders• Axis I disorders (e.g., depression, anxiety, somat<strong>of</strong>orm)• Axis II disorders (e.g., borderline personality, sociopathic personality)• Encephalopathy (confusion in dose and interval <strong>of</strong> prescription)• Criminal intent

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!